Coeptis Therapeutics, Inc.
General ticker "COEP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $131.2M (TTM average)
Coeptis Therapeutics, Inc. follows the US Stock Market performance with the rate: 43.4%.
Estimated limits based on current volatility of 4.8%: low 12.82$, high 14.13$
Factors to consider:
- Total employees count: 5 (0.0%) as of 2022
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.62$, 24.04$]
- 2026-12-31 to 2027-12-31 estimated range: [5.60$, 16.86$]
Financial Metrics affecting the COEP estimates:
- Negative: with PPE of -5.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.77 <= 0.07
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -14.62 <= 0
- Positive: Shareholder equity ratio, % of 86.94 > 64.25
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term COEP quotes
Long-term COEP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $1.36MM |
| Operating Expenses | $21.49MM | $10.05MM | $14.41MM |
| Operating Income | $-21.49MM | $-10.05MM | $-13.04MM |
| Non-Operating Income | $0.22MM | $-0.82MM | $0.77MM |
| Interest Expense | $0.11MM | $0.40MM | $0.64MM |
| R&D Expense | $6.67MM | $2.33MM | $1.28MM |
| Income(Loss) | $-21.27MM | $-10.88MM | $-12.28MM |
| Profit(Loss)* | $-21.27MM | $-10.88MM | $-11.92MM |
| Stockholders Equity | $4.31MM | $3.19MM | $17.25MM |
| Assets | $8.07MM | $8.91MM | $19.84MM |
| Operating Cash Flow | $-7.24MM | $-6.65MM | $-8.60MM |
| Financing Cash Flow | $4.92MM | $5.71MM | $13.74MM |
| Earnings Per Share** | $-0.83 | $-5.65 | $-2.81 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.